GDPR Compliance and Cookie Policy. View in detail
-19% MEGALAC Almasilate suspension, 20x10 ml

MEGALAC Almasilate suspension, 20x10 ml

MEGALAC Almasilat Suspension

Manufacturers: HERMES Arzneimittel GmbH

PZN: 04678414

Dosage: Suspension

Content: 20X10 ml

Reward Points: 93

Availability: In stock

$18.70

$15.07

from German pharmacies to your address

0 reviews / Write a review

-19% MEGALAC Almasilate suspension, 20x10 ml
  • MEGALAC Almasilate suspension, 20x10 ml
  • MEGALAC Almasilate suspension, 20x10 ml

Instructions for use for MEGALAC Almasilate suspension, 20x10 ml

Megalac almasilate suspension bag

Active pharmaceutical ingredients:
10 ml (= 2 teaspoons) included: 1.0 g almasilate (aluminum magnesium silicathydrate), corresponding to 0.2 g aluminum oxide and 0.3 g magnesium oxide (corresponding to a neutralization capacity of at least 11 mval).
 
Application areas:
For the symptomatic treatment of diseases in which the stomach acid is to be bound: - stomach and duodenal intestine ulcers, - heartburn and acid -related stomach complaints.
 
Warning: regular contrast d. Al-bloodspiegel at Langzeitenwend. (Do not exceed 40 µg/l). 10 ml relax. 0.025 BE.

Detailed instructions for MEGALAC Almasilate suspension, 20x10 ml

Field of use

  • The medicine is a means of binding excess stomach acid (antacid).
  • The drug is used for the symptomatic treatment of diseases in which the stomach acid is to be bound:
    • Gastrointestinal and duodenal ulcers
    • Heartburn and acid -related stomach complaints

Active ingredients / ingredients / ingredients

1 g almasilate
Neutralization capacity
200 mg aluminum oxid
300 mg magnesium oxide
Hyetellose auxiliary substance (+)
Povidon K25 Hedge substance (+)
Propylen glycol auxiliary substance (+)
Saccharin, sodium salt auxiliary material (+)
Sorbitol auxiliary substance (+)
Water, cleaned auxiliary material (+)
0.025 Be carbohydrates Hedge material (+)
Caramel aroma Hedge substance (+)

Contradictions

  • The medicine must not be taken
    • if you are hypersensitive (allergic) against almasilate or one of the other components of the medicine,
    • with a downgraded phosphate concentration in the blood (pituitary memia).
    • Children and adolescents under the age of 12
      • The drug should not be used in children under the age of 12, since there is no sufficient experiences in this age group.

dosage

  • Always take the medicine exactly according to the instruction. Please ask your doctor or pharmacist if you are not quite sure.
    • Unless otherwise prescribed by the doctor, the usual dose is:
      • Unless otherwise prescribed, take 10 ml from the medicine (= 1 bag) 4 times a day.

 

  • Duration of the application
    • The duration of the treatment depends on the type and severity and the course of the disease.
    • If the symptoms remain below the treatment for more than 2 weeks, a doctor should be consulted.
    • Please speak to your doctor or pharmacist if you have the impression that the effect of the medicine is too strong or too weak.

 

  • If you have taken a larger amount of the medicine than you should
    • Poisoning with the medicine is not known or expected.
    • When overdosing, there may be changes in stool behavior such as stool deviation and increase in the frequency of stool.
    • Therapeutic measures are generally not necessary here.

 

  • If you forgot to take the medicine
    • If you no longer take the drug next time, continue treatment with the prescribed dose.

 

  • If you cancel the intake of the medicine
    • Definitely speak to your doctor before you - e.g. B. due to the occurrence of side effects - interrupt the treatment with the medicinal product or end it prematurely.

 

  • If you have any further questions about the application of the drug, ask your doctor or pharmacist.

Taking

  • To take.
  • The intake should take place undiluted 1-2 hours after meals and before going to bed.

Patient information

  • Particular caution when taking the medicine is required
    • Long -lasting and recurring stomach complaints can be signs of a serious illness, such as: B. a stomach or duodenal ulcer. Treatment with the medicine should therefore not take longer than 14 days without a medical examination. A doctor must be consulted immediately if the tea chair appears, blood diploma in the stool or vomiting of blood.
    • With long -term use of the medicine, regular checks of aluminum serum levels are required. 40 µg/l should not be exceeded.
    • In patients with restricted kidney function and chronic intake of high doses, there is the possibility of poisoning such as an increase in magnesium or aluminum levels in the blood.
    • With long -term intake of high doses and low -phosphate diet, the risk of bone deviation (osteomalacia) can lead to phosphate raving. In patients with restricted kidney function, long -term intake should be avoided.

 

  • Wateriness and operating machines:
    • There are no special features to consider.

Pregnancy

  • Pregnancy and breast feeding period
    • The benefit-risk ratio should be carefully weighed before taking aluminum-containing antacida during pregnancy. The drug should only be used in the short term during pregnancy to avoid aluminum pollution from the child.
    • Aluminum compounds pass into breast milk. A risk for the newborn cannot be assumed because only very small quantities are recorded.
    • Ask your doctor or pharmacist for advice before taking / using all drugs.

Hints

Read the package supplement and ask your doctor or pharmacist for risks and side effects.

Miscellaneous

- Part of the aluminum is absorbed and leads to an increase in the concentrations of aluminum in the blood and an increase in aluminum excretion over the kidneys.
- The aluminum values remain below the toxic area and normalize in 3-4 days after the medicine is taken.
- A small part of the magnesium is recorded. The magnesium concentration in the blood usually remains unchanged by excretion through the kidneys.
- With limited kidney function and long-term intake of high quantities, a magnesium surplus up to magnesium poisoning and aluminum storage can occur, especially in the nerve and bone fabric.
- The aluminum values should be checked regularly with long -term use and do not exceed 40g/l. This applies in particular with existing reduced kidney function.
- In the case of long -lasting or/and at more frequent intervals recurring complaints, a serious disease such as a stomach ulcer or malice should be excluded.
- In the case of gastric or small intestine ulcers, an examination for a certain pathogen (helicobacter pylori) should be carried out in order to carry out a corresponding treatment in the positive case.

Manufacturer:  HERMES Arzneimittel GmbH, Georg-Kalb-Straße 5-8, 82049 Grosshesselohe

Medicines Reviews

There are no reviews for this product.

Write a review

* Rating Bad Good

Popular in Heartburn

-30% SOBRADE chewable tablets, 20 pcs

SOBRADE chewable tablets, 20 pcs

SOBRADE Kautabletten

$8.33 $11.95

-32% TALCID chewing tablets, 100 pcs

TALCID chewing tablets, 100 pcs

TALCID Kautabletten

$27.73 $40.99

-28% RENNIE chewing tablets, 60 pcs

RENNIE chewing tablets, 60 pcs

RENNIE Kautabletten

$14.84 $20.74

-33% GAVISCON Dual 250mg/106.5 mg/187.5 mg chewing tablets, 48 pcs

GAVISCON Dual 250mg/106.5 mg/187.5 mg chewing tablets, 48 pcs

GAVISCON Dual 250mg/106,5mg/187,5mg Kautabletten

$19.30 $28.88

-26% GAVISCON Advance peppermint suspension, 24x10 ml

GAVISCON Advance peppermint suspension, 24x10 ml

GAVISCON Advance Pfefferminz Suspension

$24.13 $32.55

-25% TALCID chewing tablets, 20 pcs

TALCID chewing tablets, 20 pcs

TALCID Kautabletten

$7.47 $10.01

-50% OMEP HEXAL 20 mg gastric -resistant hard capsules, 14 pcs

OMEP HEXAL 20 mg gastric -resistant hard capsules, 14 pcs

OMEP HEXAL 20 mg magensaftresistente Hartkapseln

$8.80 $17.71

-26% GAVISCON Dual 250mg/106.5 mg/187.5 mg chewing tablets, 16 pcs

GAVISCON Dual 250mg/106.5 mg/187.5 mg chewing tablets, 16 pcs

GAVISCON Dual 250mg/106,5mg/187,5mg Kautabletten

$7.99 $10.83